"Drug Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.
Descriptor ID |
D016903
|
MeSH Number(s) |
E01.370.520.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Monitoring".
Below are MeSH descriptors whose meaning is more specific than "Drug Monitoring".
This graph shows the total number of publications written about "Drug Monitoring" by people in this website by year, and whether "Drug Monitoring" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
1998 | 1 | 1 | 2 |
1999 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2001 | 0 | 2 | 2 |
2002 | 1 | 2 | 3 |
2003 | 2 | 5 | 7 |
2004 | 3 | 5 | 8 |
2005 | 1 | 2 | 3 |
2006 | 2 | 4 | 6 |
2007 | 2 | 8 | 10 |
2008 | 4 | 4 | 8 |
2009 | 0 | 4 | 4 |
2010 | 2 | 6 | 8 |
2011 | 4 | 8 | 12 |
2012 | 5 | 9 | 14 |
2013 | 5 | 7 | 12 |
2014 | 5 | 8 | 13 |
2015 | 1 | 13 | 14 |
2016 | 4 | 10 | 14 |
2017 | 3 | 10 | 13 |
2018 | 2 | 5 | 7 |
2019 | 5 | 7 | 12 |
2020 | 4 | 11 | 15 |
2021 | 0 | 9 | 9 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Monitoring" by people in Profiles.
-
Therapeutic drug monitoring of methotrexate in patients with Crohn's disease. Aliment Pharmacol Ther. 2023 12; 58(11-12):1151-1162.
-
Milrinone therapeutic drug monitoring to reduce low cardiac output syndrome in pediatric patients. Can J Anaesth. 2023 05; 70(5):922-924.
-
Multidisciplinary management of anticoagulation therapy with International Normalized Ratio monitoring in general practice. Int J Clin Pract. 2021 Nov; 75(11):e14741.
-
Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Liver Transpl. 2022 01; 28(1):127-130.
-
Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:2-6.
-
Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis. J Crohns Colitis. 2021 Jun 22; 15(6):1032-1048.
-
Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther. 2021 08; 35(4):793-800.
-
Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer. Br J Cancer. 2021 06; 124(12):1970-1977.
-
Inorganic Nitrite Supplementation Improves Endothelial Function With Aging: Translational Evidence for Suppression of Mitochondria-Derived Oxidative Stress. Hypertension. 2021 04; 77(4):1212-1222.
-
The Right Dose: From Phase I to Clinical Practice. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:92-106.